Abstract
There is increasing evidence that gene copy number (CN) variation influences clinical phenotype. The low-affinity Fc receptor 3B (FCGR3B) located in the FCGR gene cluster is a CN polymorphic gene involved in the recruitment of polymorphonuclear neutrophils to sites of inflammation and their activation. Given the genetic overlap between systemic lupus erythematosus and systemic sclerosis (SSc) and the strong evidence for FCGR3B CN in the pathology of SLE, we hypothesised that FCGR3B gene dosage influences susceptibility to SSc. We obtained FCGR3B deletion status in 777 European Caucasian cases and 1000 controls. There was an inverse relationship between FCGR3B CN and disease susceptibility. CN of ⩽1 was a significant risk factor for SSc (OR=1.55 (1.13–2.14), P=0.007) relative to CN⩾2. Although requiring replication, these results suggest that impaired immune complex clearance arising from FCGR3B deficiency contributes to the pathology of SSc, and FCGR3B CN variation is a common risk factor for systemic autoimmunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allanore Y, Dieude P, Boileau C . Genetic background of systemic sclerosis: autoimmune genes take centre stage. Rheumatology 2010; 49: 203–210.
McKinney C, Fanciulli M, Merriman ME, Phipps-Green A, Alizadeh BZ, Koeleman BP et al. Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis 2010; 69: 1711–1716.
Graf SW, Lester S, Nossent H, Hill CL, Proudman S, Lee A et al. Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Res Ther 2012; 14: R28.
Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P et al. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Hum Mutat 2012; 33: 741–749.
Asano K, Matsushita T, Umeno J, Hosono N, Takahashi A, Kawaguchi T et al. A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet 2009; 41: 1325–1329.
Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006; 439: 851–855.
Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007; 39: 721–723.
Mamtani M, Anaya JM, He W, Ahuja SK . Association of copy number variation in the FCGR3B gene with risk of autoimmune diseases. Genes Immun 2010; 11: 155–160.
Molokhia M, Fanciulli M, Petretto E, Patrick AL, McKeigue P, Roberts AL et al. FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. Rheumatology 2011; 50: 1206–1210.
Morris DL, Roberts AL, Witherden AS, Tarzi R, Barros P, Whittaker JC et al. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet 2010; 18: 1027–1031.
Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet 2010; 19: 3282–3294.
Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008; 205: 1573–1582.
McKinney C, Merriman TR . Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes. Hum Mol Genet 2012; 21: 2370–2376.
Nossent JC, Rischmueller M, Becker-Merok A, Lester S . Low copy number of Fcgamma receptor 3B gene is a disease susceptibility and severity factor in primary Sjogren′s syndrome. Arthritis Rheum 2011; 63: S389.
Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009; 30: E640–E650.
Marques RB, Thabet MM, White SJ, Houwing-Duistermaat JJ, Bakker AM, Hendriks GJ et al. Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis. PLoS One 2010; 5: e13173.
Katsumoto TR, Whitfield ML, Connolly MK . The pathogenesis of systemic sclerosis. Annu Rev Pathol 2011; 6: 509–537.
Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood 2008; 111: 1029–1038.
Davies KA, Peters AM, Beynon HL, Walport MJ . Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies. J Clin Invest 1992; 90: 2075–8203.
Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 1980; 23: 581–590.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–205.
Cukier HN, Pericak-Vance MA, Gilbert JR, Hedges DJ . Sample degradation leads to false-positive copy number variation calls in multiplex real-time polymerase chain reaction assays. Anal Biochem 2009; 386: 288–290.
Morgan AW, Barrett JH, Griffiths B, Subramanian D, Robinson JI, Keyte VH et al. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther 2006; 8: R5.
Acknowledgements
The Health Research Council of NZ and NZ Lottery Health are thanked for financial support. JM was funded by grant SAF2009-11110 from the Spanish Ministry of Science, CTS-4977 from Junta de Andalucía, Spain, by Redes Temáticas de Investigación Cooperativa Sanitaria Programme, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), Spain, and by Fondo Europeo de Desarrollo Regional (FEDER).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Genes and Immunity website
Supplementary information
Rights and permissions
About this article
Cite this article
McKinney, C., Broen, J., Vonk, M. et al. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun 13, 458–460 (2012). https://doi.org/10.1038/gene.2012.15
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gene.2012.15
Keywords
This article is cited by
-
FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis
Human Genetics (2016)
-
Hardy-Weinberg equilibrium revisited for inferences on genotypes featuring allele and copy-number variations
Scientific Reports (2015)
-
Association between FCGR3B copy number variations and susceptibility to autoimmune diseases: a meta-analysis
Inflammation Research (2015)
-
Changes in renal medulla gene expression in a pre-clinical model of post cardiopulmonary bypass acute kidney injury
BMC Genomics (2014)
-
Technical considerations for genotyping multi-allelic copy number variation (CNV), in regions of segmental duplication
BMC Genomics (2014)